Patents by Inventor Han-Ju Yi

Han-Ju Yi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • AMINOCARBONYLCARBAMATE COMPOUNDS
    Publication number: 20230218562
    Abstract: The present disclosure provides a compound represented by Formula (I) and a pharmaceutically acceptable salt which are effective as a dopamine reuptake inhibitor and a method of using the compound: wherein X is independently halo, alkyl, alkoxy or nitro; m is 0, 1, 2, 3 or 4; n is 1 or 2; R1 and R2 are independently H— or alkyl; R3 is H—, alkyl or aralkyl; and R4 is H— or aryl.
    Type: Application
    Filed: March 22, 2023
    Publication date: July 13, 2023
    Inventors: Young-Soon KANG, Jin-Yong CHUNG, Cheol-Young MAENG, Han-Ju YI, Ki-Ho LEE, Joon HEO, Eun-Hee CHAE, Yu-Jin SHIN
  • Use of a carbamate compound to prevent, alleviate or treat visceralgia or pain arising from visceral disease
    Patent number: 11666554
    Abstract: The present invention relates to use of a carbonate compound of chemical formula 1, or a pharmaceutically permissible salt, solvate or hydrate thereof, for prevention, alleviation or treatment of visceralgia, or pain arising from visceral disease.
    Type: Grant
    Filed: November 13, 2018
    Date of Patent: June 6, 2023
    Assignee: SK BIOPHARMACEUTICALS CO., LTD.
    Inventor: Han Ju Yi
  • USE OF CARBAMATE COMPOUND FOR PREVENTING OR TREATING TRIGEMINAL NEURALGIA
    Publication number: 20220087976
    Abstract: The present invention relates to a pharmaceutical composition for preventing or treating trigeminal neuralgia, the pharmaceutical composition comprising: a carbamate compound of chemical formula 1 or a pharmaceutically acceptable salt thereof, a solvate or a hydrate; and a pharmaceutically acceptable carrier. The pharmaceutical composition, according to the present invention, may enable the efficient prevention or treatment of trigeminal neuralgia.
    Type: Application
    Filed: December 2, 2021
    Publication date: March 24, 2022
    Inventors: Min Jae JO, Sun Gwan HWANG, Han Ju YI
  • Use of carbamate compound for preventing or treating trigeminal neuralgia
    Patent number: 11207295
    Abstract: The present invention relates to a pharmaceutical composition for preventing or treating trigeminal neuralgia, the pharmaceutical composition comprising: a carbamate compound of chemical formula 1 or a pharmaceutically acceptable salt thereof, a solvate or a hydrate; and a pharmaceutically acceptable carrier. The pharmaceutical composition, according to the present invention, may enable the efficient prevention or treatment of trigeminal neuralgia.
    Type: Grant
    Filed: May 18, 2017
    Date of Patent: December 28, 2021
    Assignee: SK BioPharmaceuticals Co., Ltd.
    Inventors: Min Jae Jo, Sun Gwan Hwang, Han Ju Yi
  • Use of carbamate compound for preventing, alleviating, or treating tremors or tremor syndrome
    Patent number: 11033531
    Abstract: The present invention relates to a use of a pharmaceutical composition which includes a carbamate compound of chemical formula 1 and is administered to prevent, alleviate, or treat tremors or tremor syndrome.
    Type: Grant
    Filed: December 14, 2017
    Date of Patent: June 15, 2021
    Assignee: SK BIOPHARMACEUTICALS CO., LTD.
    Inventors: Jin Uk Yoo, Hye Sung Lee, Han Ju Yi
  • AMINOCARBONYLCARBAMATE COMPOUNDS
    Publication number: 20210113514
    Abstract: The present disclosure provides a compound represented by Formula (I) and a pharmaceutically acceptable salt which are effective as a dopamine reuptake inhibitor and a method of using the compound: wherein X is independently halo, alkyl, alkoxy or nitro; m is 0, 1, 2, 3 or 4; n is 1 or 2; R1 and R2 are independently H— or alkyl; R3 is H—, alkyl or aralkyl; and R4 is H— or aryl.
    Type: Application
    Filed: December 29, 2020
    Publication date: April 22, 2021
    Inventors: Young-Soon KANG, Jin-Yong CHUNG, Cheol-Young MAENG, Han-Ju YI, Ki-Ho LEE, Joon HEO, Eun-Hee CHAE, Yu-Jin SHIN
  • Aminocarbonylcarbamate compounds
    Patent number: 10888542
    Abstract: The present disclosure provides a compound represented by Formula (I) and a pharmaceutically acceptable salt which are effective as a dopamine reuptake inhibitor and a method of using the compound: wherein X is independently halo, alkyl, alkoxy or nitro; m is 0, 1, 2, 3 or 4; n is 1 or 2; R1 and R2 are independently H— or alkyl; R3 is H—, alkyl or aralkyl; and R4 is H— or aryl.
    Type: Grant
    Filed: October 16, 2019
    Date of Patent: January 12, 2021
    Assignee: SK BIOPHARMACEUTICALS CO., LTD.
    Inventors: Young-Soon Kang, Jin-Yong Chung, Cheol-Young Maeng, Han-Ju Yi, Ki-Ho Lee, Joon Heo, Eun-Hee Chae, Yu-Jin Shin
  • Use of carbamate compound for preventing or treating fibromyalgia or functional syndrome associated with fibromyalgia
    Patent number: 10849882
    Abstract: The present invention relates to a pharmaceutical composition for preventing or treating fibromyalgia or a functional syndrome associated with fibromyalgia, the pharmaceutical composition comprising: a carbamate compound of chemical formula 1 or a pharmaceutically acceptable salt thereof, a solvate or a hydrate; and a pharmaceutically acceptable carrier. The pharmaceutical composition, according to the present invention, may enable the efficient treatment of fibromyalgia or a functional syndrome associated with fibromyalgia.
    Type: Grant
    Filed: May 18, 2017
    Date of Patent: December 1, 2020
    Assignee: SK BIOPHARMACEUTICALS CO., LTD.
    Inventors: Min Jae Jo, Han Ju Yi, Sun Gwan Hwang
  • Use Of A Carbamate Compound To Prevent, Alleviate Or Treat Visceralgia Or Pain Arising From Visceral Disease
    Publication number: 20200368203
    Abstract: The present invention relates to use of a carbonate compound of chemical formula 1, or a pharmaceutically permissible salt, solvate or hydrate thereof, for prevention, alleviation or treatment of visceralgia, or pain arising from visceral disease.
    Type: Application
    Filed: November 13, 2018
    Publication date: November 26, 2020
    Inventor: Han Ju YI
  • AMINOCARBONYLCARBAMATE COMPOUNDS
    Publication number: 20200046674
    Abstract: The present disclosure provides a compound represented by Formula (I) and a pharmaceutically acceptable salt which are effective as a dopamine reuptake inhibitor and a method of using the compound: wherein X is independently halo, alkyl, alkoxy or nitro; m is 0, 1, 2, 3 or 4; n is 1 or 2; R1 and R2 are independently H— or alkyl; R3 is H—, alkyl or aralkyl; and R4 is H— or aryl.
    Type: Application
    Filed: October 16, 2019
    Publication date: February 13, 2020
    Inventors: Young-Soon KANG, Jin-Yong CHUNG, Cheol-Young MAENG, Han-Ju YI, Ki-Ho LEE, Joon HEO, Eun-Hee CHAE, Yu-Jin SHIN
  • Aminocarbonylcarbamate compounds
    Patent number: 10485781
    Abstract: The present disclosure provides a compound represented by Formula (I) and a pharmaceutically acceptable salt which are effective as a dopamine reuptake inhibitor and a method of using the compound: wherein X is independently halo, alkyl, alkoxy or nitro; m is 0, 1, 2, 3 or 4; n is 1 or 2; R1 and R2 are independently H— or alkyl; R3 is H—, alkyl or aralkyl; and R4 is H— or aryl.
    Type: Grant
    Filed: April 26, 2019
    Date of Patent: November 26, 2019
    Assignee: SK BIOPHARMACEUTICALS CO., LTD.
    Inventors: Young-Soon Kang, Jin-Yong Chung, Cheol-Young Maeng, Han-Ju Yi, Ki-Ho Lee, Joon Heo, Eun-Hee Chae, Yu-Jin Shin
  • USE OF CARBAMATE COMPOUND FOR PREVENTING, ALLEVIATING, OR TREATING TREMORS OR TREMOR SYNDROME
    Publication number: 20190336481
    Abstract: The present invention relates to a use of a pharmaceutical composition which includes a carbamate compound of chemical formula 1 and is administered to prevent, alleviate, or treat tremors or tremor syndrome.
    Type: Application
    Filed: December 14, 2017
    Publication date: November 7, 2019
    Inventors: Jin Uk YOO, Hye Sung LEE, Han Ju YI
  • Use Of Carbamate Compound For Preventing Or Treating Fibromyalgia Or Functional Syndrome Associated With Fibromyalgia
    Publication number: 20190298694
    Abstract: The present invention relates to a pharmaceutical composition for preventing or treating fibromyalgia or a functional syndrome associated with fibromyalgia, the pharmaceutical composition comprising: a carbamate compound of chemical formula 1 or a pharmaceutically acceptable salt thereof, a solvate or a hydrate; and a pharmaceutically acceptable carrier. The pharmaceutical composition, according to the present invention, may enable the efficient treatment of fibromyalgia or a functional syndrome associated with fibromyalgia.
    Type: Application
    Filed: May 18, 2017
    Publication date: October 3, 2019
    Inventors: Min Jae JO, Han Ju YI, Sun Gwan HWANG
  • Aminocarbonylcarbamate Compounds
    Publication number: 20190247356
    Abstract: The present disclosure provides a compound represented by Formula (I) and a pharmaceutically acceptable salt which are effective as a dopamine reuptake inhibitor and a method of using the compound: wherein X is independently halo, alkyl, alkoxy or nitro; m is 0, 1, 2, 3 or 4; n is 1 or 2; R1 and R2 are independently H— or alkyl; R3 is H—, alkyl or aralkyl; and R4 is H— or aryl.
    Type: Application
    Filed: April 26, 2019
    Publication date: August 15, 2019
    Inventors: Young-Soon KANG, Jin-Yong CHUNG, Cheol-Young MAENG, Han-Ju YI, Ki-Ho LEE, Joon HEO, Eun-Hee CHAE, Yu-Jin SHIN
  • Use Of Carbamate Compound For Preventing Or Treating Trigeminal Neuralgia
    Publication number: 20190175555
    Abstract: The present invention relates to a pharmaceutical composition for preventing or treating trigeminal neuralgia, the pharmaceutical composition comprising: a carbamate compound of chemical formula 1 or a pharmaceutically acceptable salt thereof, a solvate or a hydrate; and a pharmaceutically acceptable carrier. The pharmaceutical composition, according to the present invention, may enable the efficient prevention or treatment of trigeminal neuralgia.
    Type: Application
    Filed: May 18, 2017
    Publication date: June 13, 2019
    Applicant: SK BioPharmaceuticals Co., Ltd.
    Inventors: Min Jae JO, Sun Gwan HWANG, Han Ju YI
  • Aminocarbonylcarbamate compounds
    Patent number: 10314808
    Abstract: The present disclosure provides a compound represented by Formula (I) and a pharmaceutically acceptable salt which are effective as a dopamine reuptake inhibitor and a method of using the compound: wherein X is independently halo, alkyl, alkoxy or nitro; m is 0, 1, 2, 3 or 4; n is 1 or 2; R1 and R2 are independently H— or alkyl; R3 is H—, alkyl or aralkyl; and R4 is H— or aryl.
    Type: Grant
    Filed: November 7, 2017
    Date of Patent: June 11, 2019
    Assignee: SK BIOPHARMACEUTICALS CO., LTD.
    Inventors: Young-Soon Kang, Jin-Yong Chung, Cheol-Young Maeng, Han-Ju Yi, Ki-Ho Lee, Joon Heo, Eun-Hee Chae, Yu-Jin Shin
  • AMINOCARBONYLCARBAMATE COMPOUNDS
    Publication number: 20180085337
    Abstract: The present disclosure provides a compound represented by Formula (I) and a pharmaceutically acceptable salt which are effective as a dopamine reuptake inhibitor and a method of using the compound: wherein X is independently halo, alkyl, alkoxy or nitro; m is 0, 1, 2, 3 or 4; n is 1 or 2; R1 and R2 are independently H— or alkyl; R3 is H—, alkyl or aralkyl; and R4 is H— or aryl.
    Type: Application
    Filed: November 7, 2017
    Publication date: March 29, 2018
    Inventors: Young-Soon KANG, Jin-Yong CHUNG, Cheol-Young MAENG, Han-Ju YI, Ki-Ho LEE, Joon HEO, Eun-Hee CHAE, Yu-Jin SHIN
  • Aminocarbonylcarbamate compounds
    Patent number: 9833432
    Abstract: The present disclosure provides a compound represented by Formula (I) and a pharmaceutically acceptable salt which are effective as a dopamine reuptake inhibitor and a method of using the compound: wherein X is independently halo, alkyl, alkoxy or nitro; m is 0, 1, 2, 3 or 4; n is 1 or 2; R1 and R2 are independently H— or alkyl; R3 is H—, alkyl or aralkyl; and R4 is H— or aryl.
    Type: Grant
    Filed: June 28, 2016
    Date of Patent: December 5, 2017
    Assignee: SK BIOPHARMACEUTICALS CO., LTD.
    Inventors: Young-Soon Kang, Jin-Yong Chung, Cheol-Young Maeng, Han-Ju Yi, Ki-Ho Lee, Joon Heo, Eun-Hee Chae, Yu-Jin Shin
  • AMINOCARBONYLCARBAMATE COMPOUNDS
    Publication number: 20160303067
    Abstract: The present disclosure provides a compound represented by Formula (I) and a pharmaceutically acceptable salt which are effective as a dopamine reuptake inhibitor and a method of using the compound: wherein X is independently halo, alkyl, alkoxy or nitro; m is 0, 1, 2, 3 or 4; n is 1 or 2; R1 and R2 are independently H— or alkyl; R3 is H—, alkyl or aralkyl; and R4 is H— or aryl.
    Type: Application
    Filed: June 28, 2016
    Publication date: October 20, 2016
    Inventors: Young-Soon KANG, Jin-Yong CHUNG, Cheol-Young MAENG, Han-Ju YI, Ki-Ho LEE, Joon HEO, Eun-Hee CHAE, Yu-Jin SHIN
  • Aminocarbonylcarbamate compounds
    Patent number: 9403761
    Abstract: The present disclosure provides a compound represented by Formula (I) and a pharmaceutically acceptable salt which are effective as a dopamine reuptake inhibitor and a method of using the compound: wherein X is independently halo, alkyl, alkoxy or nitro; m is 0, 1, 2, 3 or 4; n is 1 or 2; R1 and R2 are independently H— or alkyl; R3 is H—, alkyl or aralkyl; and R4 is H— or aryl.
    Type: Grant
    Filed: February 27, 2015
    Date of Patent: August 2, 2016
    Assignee: SK BIOPHARMACEUTICALS CO., LTD.
    Inventors: Young-Soon Kang, Jin-Yong Chung, Cheol-Young Maeng, Han-Ju Yi, Ki-Ho Lee, Joon Heo, Eun-Hee Chae, Yu-Jin Shin